Takeda Pharmaceutical Company Limited
The Vice President, Global Clinical Lead — Solid Tumor is a senior executive role within Takeda’s Oncology Clinical Sciences focused on the global development of solid tumor therapies across early and late-stage programs. The position is based in the Boston/Cambridge area (hybrid) and supports Takeda’s R&D efforts to advance oncology treatments globally.
Takeda is a patient-focused, R&D-driven global biopharmaceutical company committed to bringing Better Health and a Brighter Future.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Takeda Pharmaceutical Company Limited.
Takeda plans to lay off 400 employees in US - report
2 weeks ago
Vice President, Global Clinical Lead - Solid Tumor
BioLife Plasma Services
Medical Director, Clinical Development, Solid Tumor Oncology
Regeneron Pharmaceuticals
Senior Director Clinical Development, Solid Tumor
lifelancer
Executive Director, Global Product Leader (GPL – Solid Tumor Franchise)
AstraZeneca
Global Project Head, Solid Tumor Immuno-Oncology
sanofi us
Faculty position, Department of Oncology – Solid Tumor Division
St. Jude Children's Research Hospital